ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0886

Neonatal Roseolovirus Infection Predisposes to Development of Lupus-like Disease After TLR7 Stimulation

Tarin Bigley1, Eden Xue1, Lifei Zhu1, Li-ping Yang1 and wayne Yokoyama2, 1Washington University in St. Louis, St. Louis, MO, 2Washington University School of Medicine, St. Louis, MO

Meeting: ACR Convergence 2023

Keywords: Infection, interferon, Mouse Models, Lupus, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0886–0898) SLE – Animal Models Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Viral infections have been implicated as major factors in autoimmune disease but demonstrating causality is often challenging. We found that neonatal infection with a roseolovirus (murine roseolovirus, MRV) resulted in transient thymic atrophy, CD4+ T cell depletion, and disruption of central tolerance. Although mice recovered from infection, we observed durable immune dysregulation manifested as autoimmune gastritis and a broad repertoire of autoantibodies. In these studies, we found that additional immune stimulation resulted in systemic autoimmunity.

Methods: We developed a mouse model in which neonatally infected C57BL/6 mice were treated with a toll-like receptor 7 (TLR7) agonist as adults to induce a lupus-like phenotype. Histology, immunofluorescence, ELISA, transcription analysis as well as flow cytometry were used to characterize disease and evaluate immune dysregulation. We used depletion and adoptive transfer experiments to identify the contribution of specific cell types to disease.

Results: We found that MRV replication during the first seven days of life induced a loss of central tolerance and development of autoimmune gastritis and autoantibodies, including those typically associated with autoimmune connective tissue disease. Interestingly, treatment with a TLR7 agonist induced a systemic autoimmune disease with characteristics observed in systemic lupus erythematosus, including splenomegaly, cytopenia, positive ANA, and multi-organ system inflammation in mice. In C57BL/6 mice, this lupus-like disease was only observed after neonatal MRV infection. Although a feature of MRV-induced lupus-like disease was significant thymic disruption, we did not observe MRV reactivation after TLR7 stimulation. We also observed major changes in the phenotype of T and B cells in the blood and spleen, suggesting a shift in the number and activation of different subsets. Moreover, we found that T and B cells play different roles in development of disease.

Conclusion: We have shown that MRV induces autoimmune after neonatal infection in a murine system. Moreover, our data suggest that neonatal MRV infection not only induces mild, organ-specific autoimmunity, but also results in durable immune dysregulation and predisposition to severe systemic autoimmunity after additional immune stimulation.


Disclosures: T. Bigley: None; E. Xue: None; L. Zhu: None; L. Yang: None; w. Yokoyama: None.

To cite this abstract in AMA style:

Bigley T, Xue E, Zhu L, Yang L, Yokoyama w. Neonatal Roseolovirus Infection Predisposes to Development of Lupus-like Disease After TLR7 Stimulation [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/neonatal-roseolovirus-infection-predisposes-to-development-of-lupus-like-disease-after-tlr7-stimulation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neonatal-roseolovirus-infection-predisposes-to-development-of-lupus-like-disease-after-tlr7-stimulation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology